Company news

Telesis Bio, Inc. news in 2025

Telesis Bio, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

May 28, 2025

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis

March 18, 2025

Decks in 2025